Literature DB >> 15368282

Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines.

Henry Lin1, Mie Nieda, Andrew J Nicol.   

Abstract

Human Valpha24(+)Vbeta11(+) NKT (NKT) cells have immune regulatory activities associated with rejection of tumors, infections and control of autoimmune diseases. They can be stimulated to proliferate using alpha-galactosylceramide (KRN7000) and have the potential for therapeutic manipulation. Subpopulations of NKT cells (CD4(+)CD8(-), CD4(-)CD8(+) and CD4(-)CD8(-)) have functionally distinctive Th1/Th2 cytokine profiles and their relative numbers following stimulation may influence the Th1/Th2 balance, which may result in or prevent disease. We aimed to determine the effect of different cytokines in culture during stimulation of NKT cells on the relative proportions of NKT cell subpopulations. Our results show that all NKT cell subpopulations expanded following stimulation with KRN7000 and IL-2, IL-7, IL-12 or IL-15. Expansion capacity differed between subpopulations, resulting in different relative proportions of CD4(+) and CD4(-) NKT cell subpopulations, and this was influenced by the cytokine used for stimulation. A Th1-biased environment was observed after stimulation of NKT cells. NKT cells expanded under all conditions evaluated demonstrated significant cytotoxicity against U937 tumor cells. In view of the potential for NKT cell subsets to alter the balance of Th1 and Th2 environment, these data provide insights into the effects of NKT cell manipulation for possible therapeutic applications in different disease settings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368282     DOI: 10.1002/eji.200324834

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Invariant NKT cells increase drug-induced osteosarcoma cell death.

Authors:  S Fallarini; T Paoletti; N Orsi Battaglini; G Lombardi
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Characterization of human invariant natural killer T cells expressing FoxP3.

Authors:  Péter Engelmann; Klára Farkas; János Kis; Geoffrey Richman; Zhaoyun Zhang; Chong Wee Liew; Maciej Borowiec; Monika A Niewczas; Heyam Jalahej; Tihamér Orbán
Journal:  Int Immunol       Date:  2011-06-27       Impact factor: 4.823

3.  Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys.

Authors:  Namita Rout; James G Else; Simon Yue; Michelle Connole; Mark A Exley; Amitinder Kaur
Journal:  J Med Primatol       Date:  2010-08       Impact factor: 0.667

4.  Transcriptional control of invariant NKT cell development.

Authors:  Rupali Das; Derek B Sant'Angelo; Kim E Nichols
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.

Authors:  Robert Weinkove; Collin R Brooks; John M Carter; Ian F Hermans; Franca Ronchese
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

6.  T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.

Authors:  R V Anantha; D M Mazzuca; S X Xu; S A Porcelli; D D Fraser; C M Martin; I Welch; T Mele; S M M Haeryfar; J K McCormick
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

7.  Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro.

Authors:  Venkata Ramanarao Parasa; Anbalagan Selvaraj; Rajasekaran Sikhamani; Alamelu Raja
Journal:  Clin Exp Med       Date:  2014-04-20       Impact factor: 3.984

8.  Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells.

Authors:  Vincent O'Reilly; Shijuan G Zeng; Gabriel Bricard; Ann Atzberger; Andrew E Hogan; John Jackson; Conleth Feighery; Steven A Porcelli; Derek G Doherty
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  Differential antitumor immunity mediated by NKT cell subsets in vivo.

Authors:  Nadine Y Crowe; Jonathan M Coquet; Stuart P Berzins; Konstantinos Kyparissoudis; Rachael Keating; Daniel G Pellicci; Yoshihiro Hayakawa; Dale I Godfrey; Mark J Smyth
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

10.  Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Authors:  Joanne E Croudace; Stuart M Curbishley; Manuela Mura; Carrie R Willcox; Petr A Illarionov; Gurdyal S Besra; David H Adams; David A Lammas
Journal:  BMC Immunol       Date:  2008-12-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.